Why the study?
Coeliac disease is accurately diagnosed via invasive duodenal biopsy, making non-invasive liquid biopsy an appealing alternative for disease detection.
Can an electrochemical PNA device accurately detect miRNA-486-5p in serum for non-invasive coeliac disease diagnosis compared to RT-qPCR?
Can an electrochemical PNA device accurately detect miRNA-486-5p in serum for non-invasive coeliac disease diagnosis compared to RT-qPCR?
A novel electrochemical PNA device offers a sensitive, non-invasive method for detecting miRNA-486-5p in serum, potentially aiding in coeliac disease diagnosis.
Answers are grounded in this paper and cite their sources.
May enable non-invasive miRNA-based coeliac diagnostics; leaves open prospective human validation before clinical adoption.
Coeliac disease is a very common autoimmune disease estimated to affect 1 in 100 people worldwide. It occurs in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine, and it is accurately diagnosticated through duodenal biopsy, an invasive diagnostic method. The liquid biopsy, generally used for monitoring cancer, is an appealing alternative even for autoimmune pathology such as coeliac disease, allowing for detecting disease progression or resistance to treatment. For this reason, an electrochemical peptide nucleic acid (PNA) device combined with a smartphone‐assisted potentiostat for non‐invasive coeliac disease diagnosis is proposed, by measuring the selected overexpressed miRNA‐486‐5p in serum, enlarging the application of liquid biopsy in nontumor pathologies. For highly sensitive detection, the polyester‐based printed sensor is nanomodified with gold nanoparticles and a synthetic customized PNA probe. The designed sensor can detect the target analyte in the range of 10–100 n m with a limit of detection of 0.7 n m by measuring the variation of the response of the electrochemical mediator hexaammineruthenium in the presence of PNA–miRNA duplex on the nanostructured working electrode surface. The analyses testing serum samples are found in agreement with ones obtained by real‐time quantitative polymerase chain reaction (RT‐qPCR), demonstrating the reliability of this innovative electrochemical chip developed.
No takes yet. Share an insight, caveat, or question.
Caratelli et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: